CEFOTAXIME PANPHARMA 2 g, powder for solution for injection (IM-IV) 10 bottles of 15 ml
Active ingredients: Cefotaxime, Cefotaxime sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection10 bottles of 15 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFOTAXIME PANPHARMA 2 g, poudre pour solution injectable (IM-IV)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 flacon(s) de 15 ml en verre de 2 g
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Sept 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65424833CIP75501374CIP133400955013747Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFOTAXIME SODIQUEpoudre | 2,096 g · un flacon | SA |
| CÉFOTAXIMEpoudre | 2 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.